Cargando…
Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631660/ https://www.ncbi.nlm.nih.gov/pubmed/35972768 http://dx.doi.org/10.1182/bloodadvances.2022008513 |
_version_ | 1784823862299459584 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9631660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-96316602022-11-04 Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. Blood Adv Errata American Society of Hematology 2022-08-16 /pmc/articles/PMC9631660/ /pubmed/35972768 http://dx.doi.org/10.1182/bloodadvances.2022008513 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Errata Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title | Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title_full | Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title_fullStr | Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title_full_unstemmed | Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title_short | Vo P, Gooley, TA, Carpenter PA, et al. Prediction of outcomes after second-line treatment for acute graft-versus-host disease. Blood Adv. 2022;6(11):3220-3229. |
title_sort | vo p, gooley, ta, carpenter pa, et al. prediction of outcomes after second-line treatment for acute graft-versus-host disease. blood adv. 2022;6(11):3220-3229. |
topic | Errata |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631660/ https://www.ncbi.nlm.nih.gov/pubmed/35972768 http://dx.doi.org/10.1182/bloodadvances.2022008513 |